Share On Facebook and Twitter

Ebola United States

April 20, 2021

Get ready for the next pandemic its Ebola ?

ebola

 

Natural outbreaks of the Ebola virus, while severe, are typically isolated and usually affect no more than a few hundred people at a time. However, from 2014-2016, infections from Ebola  caused more than 11,000 deaths in West Africa.

During this time, several cases of Ebola were also diagnosed in the United States, due to infected african refugees and travelers from West Africa that had unknowingly harbored and incubated Ebola while en-route to the United States .

By the time a person infected with Ebola virus becomes symptomatic, they are typically starting to shed Ebola  . During an Ebola outbreak, health care workers and family members of patients are often the first to respond and provide care. In this role, they are at a high risk of becoming infected with Ebola as well. Therefore, it is important to understand how we can best prevent transmission in both clinical and home settings.

Human to human transmission of the Ebola virus occurs primarily through direct contact and exposure to the blood or other bodily fluids of infected patients. However, there have been new infections that occurred without documented contact between a patient and health care provider or family member. While these cases are uncommon, it is possible that a small fraction of the cases of Ebola virus infection may be the result of exposure to small droplets or aerosols containing the virus.

Laboratory studies have shown that the Ebola virus can remain infectious outside of the body for long periods of time. The virus can survive in blood samples on various surfaces for several days, even in hot and humid conditions that would typically kill most other viruses and bacteria. In an aerosolized form, the Ebola virus can survive for over an hour. Additionally, laboratory experiments have demonstrated that inhaling small amounts of Ebola virus can be fatal [1], and there are examples of Ebola virus disease being transmitted between individuals in close proximity, even though they had never been in direct contact with each other [2].

However, assessing the risk of transmission via droplets or aerosols is a complicated process. While the minimum amount of virus required to cause infection is thought to be very low, so far it has not been possible to determine a definitive value. This is because commonly used testing methods are often not sensitive enough to detect or measure the amount of infectious virus in the air. To address these challenges, researchers at the Department of Homeland Security (DHS) Science and Technology Directorate’s (S&T) National Biodefense Analysis and Countermeasures Center (NBACC) designed and conducted a study to optimize methods for collecting and measuring very small amounts of Ebola virus in the air.

“Ebola can be both a national security and public health concern,” explained Lloyd Hough, who leads S&T’s Hazard Awareness and Characterization Technology Center. “We’re looking forward to applying these methods to better characterize the risks associated with Ebola virus, and are hopeful that others can benefit from these techniques as well.”

NBACC researchers assessed and compared multiple devices designed for collecting microorganisms from the air. They concluded that filters made of gelatin were the best for collecting infectious Ebola virus from the air and were also the easiest and safest type of sampling device to use. The researchers utilized a cell line, developed by the Centers for Disease Control and Prevention, in an assay designed to measure the amount of infectious Ebola virus present in a sample. The cell line glows when infected by the virus, which enabled the researchers to differentiate Ebola virus infection from other causes of cell death.

After testing various sampling and assay methodologies, the NBACC researchers found that the combination of the gelatin filter samplers and improved assay was easier to use, more reliable, and nearly ten times more sensitive than the previous methods utilized to measure the amount of infectious Ebola virus in air samples. The results of these experiments have been published in two peer-reviewed journal articles [3,4], which will enable researchers at other institutions to understand and utilize these newly developed sampling and assay methodologies.

“Our ability to detect Ebola virus in air samples at levels that are ten-fold lower than what was possible with previous methods, will enable us to provide a better understanding of the aerosol hazard posed by this virus,” said Mike Schuit, an investigator in the Aerobiology group at NBACC.

The new sampling and assay methodologies developed by NBACC researchers, as well as the data from associated studies, will be useful in a number of ways. For example, these methods are currently being employed in a study in partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to determine the minimum amount of Ebola virus that needs to be inhaled in order to cause infection or death in an animal model of Ebola virus disease. This study will also determine whether infected animals produce aerosols containing Ebola virus when they breathe, which will help scientists to better understand the potential for natural aerosol transmission of the virus. Various DHS components and partners, along with the Department of Defense and the Department of Health and Human Services, will use these data to conduct hazard modeling and gain a better understanding of the potential risk for airborne transmission of Ebola virus and how it may impact health workers.

Taking lessons learned from the response to Ebola virus, the NBACC researchers are conducting similar studies with SARS-CoV-2, the virus that causes COVID-19. This includes studying the performance of aerosol samplers with SARS-CoV-2, and optimization of methodologies to detect small quantities of SARS-CoV-2 in the air. Furthermore, the NIAID partnership has been extended to examine how much virus it actually takes to start a new infection when aerosol particles containing SARS-CoV-2 are inhaled. As with the Ebola study, this study will also measure whether infectious virus is present in the exhaled breath of infected animals to better understand how COVID-19 spreads in human populations and inform strategies to prevent its continued spread.

 

 

For more information, please contact questions@nbacc.dhs.gov.

For related media inquiries, contact STMedia@hq.dhs.gov.

 

 

Airborne Ebola

Maryland, Baltimore
Job Reference
DETECTIONNA00595
You can apply to help install airborne ebola machines  here is the job ad

 

the company that is hiring airborne ebola experts is

Smiths Detection is a global leader in developing innovative screening and detection solutions used to intercept contraband and protect against explosives, chemicals, and biological threats.

located in Baltimore, MD where we develop technology for broad end-market applications including in food and agriculture safety, emerging diseases detection, and mail screening.  The advancement of high-speed, high-sensitivity pathogen detection and threat prevention solutions is part of Smiths Detection’s growth plan and overall global business strategy.

Currently, Smiths Detection has developed, and is marketing, solutions that detect a wide range of threats including anthrax, ricin, Ebola, salmonella, Phytophthora, Ralstonia, and airborne COVID-19.

 

Job Description

Smiths Detection is a global leader in developing innovative screening and detection solutions used to intercept contraband and protect against explosives, chemicals, and biological threats.  Our mission is to make the world safer by applying advanced technology to help safeguard communities, first responders, troops and transportation systems, ports, borders and buildings.

Our Center of Excellence for biological-detection capabilities is located in Baltimore, MD where we develop technology for broad end-market applications including in food and agriculture safety, emerging diseases detection, and mail screening.  The advancement of high-speed, high-sensitivity pathogen detection and threat prevention solutions is part of Smiths Detection’s growth plan and overall global business strategy.

Currently, Smiths Detection has developed, and is marketing, solutions that detect a wide range of threats including anthrax, ricin, Ebola, salmonella, Phytophthora, Ralstonia, and airborne COVID-19.

We are looking to hire a Business Development Manager – Air quality monitoring, to be based in Baltimore, MD.  This person will lead business growth across all segments of the Smiths Detection Air Quality business line to include Environmental Health & Safety (EHS) applications in corporations, entertainment, government, medical, & education. Responsibilities include developing and growing the pipeline, establishing strong relationships in the market, and guiding our go to market strategy for our air monitoring capability beginning with the SARS-CoV-2 detection business. Other duties:

Duties & Responsibilities
  • Establish sales strategies and build customer relationships in air quality market
  • Develops relationships with clients to understand key applications, generate product requirements and develop use cases
  • Build and convey compelling value propositions and work across the organization to build consensus
  • Collaborate with commercial and technical team to develop strategic plans to maximize partnership opportunities
  • Achieves or exceeds sales goals and objectives by actively selling to new clients
  • Maintains contact with existing customers as well as develops new customers to achieve or exceed sales objectives
  • Calls upon clients to develop new sales and travel throughout territory
  • Presents sales presentations for internal and external customers
  • Develops proposals on prospective opportunities
  • Utilizes the CRM database to input and manage the pipeline
  • Stays current on developments within the industry. Attends tradeshows
  • Utilizes technical expertise and expanding customer relationships to identify areas of improvement and new product opportunities
Diversity & Inclusion

We believe that different perspectives and backgrounds are what make a company flourish. All qualified applicants will receive equal consideration for employment regardless of race, color, religion, sex, sexual orientation, gender identity, national origin, economic status, disability, age, or any other legally protected characteristics. We are proud to be an inclusive company with values grounded in equality and ethics, where we celebrate, support, and embrace diversity.

The Individual
  • Education: Bachelor’s degree in Engineering, Chemistry, Microbiology or a related field, or equivalent experience
  • Have knowledge in electrical, mechanical, plumbing systems and building management system
  • Strong business skills to address business risks and identify growth opportunities, seek out and cultivate strong relationships, and capture customer priorities to guide our product development teams.
  • Ability to work independently and as a team member
  • Ability and willingness to travel up to 50%
  • Computer aptitude including MS Outlook, Power Point, Word, Excel, and CRM.
  • Excellent organizational and time management skills
  • 3-7 years of technical sales/business development experience

This is truly an exciting opportunity to support this growing business.

About Smiths

At Smiths we apply leading-edge technology to design, manufacture and deliver market-leading innovative solutions that meet our customers’ evolving needs, and touch the lives of millions of people every day. We are a FTSE100, global business of around 23,000 colleagues, based in 55 countries. Our solutions have a real impact on lives across the planet, enabling industry, improving healthcare, enhancing security, advancing connectivity and supporting new homes. Our products and services are often critical to our customers’ operations, while our proprietary technology and high service levels help create competitive advantage. We welcome colleagues with a curious mind, who are happy with responsibility, enjoy a challenge and are attracted by the idea of working at a business with an almost 170 year history of innovation, and five global divisions, all experts in their field.

About Smiths Detection

Smiths Detection is a global leader in threat detection and screening technologies for aviation, ports and borders, urban security and defence. With more than 40 years of field-tested experience, we deliver the solutions needed to protect society from the threat and illegal passage of explosives, prohibited weapons, contraband, toxic chemicals and narcotics. Every minute of every day our technology and our people make the world a safer place. Smiths Detection is part of Smiths Group, a global leader in applying advanced technologies to markets in threat as well as contraband detection, energy, medical devices, communications and engineered components. Smiths Group employs around 23,000 people in more than 50 countries.

Additional Information

Smiths Detection is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. Equal Employment Opportunity Posters If you’d like to view a copy of the company’s affirmative action plan or policy statement, please email hr-1@smiths-detection.com.

 

If you have a disability and you believe you need a reasonable accommodation in order to search for a job opening or to submit an online application, please e-mail stat@smiths.com or call toll-free 877-703-1029. This email and phone number is created exclusively to assist disabled job seekers whose disability prevents them from being able to apply online. Only messages left for this purpose will be returned. Messages left for other purposes, such as following up on an application or technical issues not related to a disability, will not receive a response. Smiths Detection, Inc. participates in the Electronic Employment Verification Program.

 


Share On Facebook and Twitter

Leave a Reply

Ebola Outbreak Map ®

Ebola Outbreak Map®

TRADEMARK REGISTRATION # 4759271

Ebola Outbreak Map registered trademark is for sale.

Imagine the possibilities of having exclusive rights for an Ebola Map.

Ebola United States

Ebola Outbreak Map® registered trademark and the website Ebola Outbreak Map is now for sale to all interested parties.

Ebola Outbreak Map . Com website tracks Ebola and locations with Ebola Monitoring. https://www.ebolaoutbreakmap.com/

Ebola Outbreak Map inputs Ebola locations onto a map that is viewable by people worldwide on Ebola Outbreak Map . Com.

Ebola Outbreak Map is trademarked no other company or corporation may have an Ebola Map.

Violation of trademark law is very serious.

Ebola Outbreak Map® is registered under the Federal Trademark Act of 1946 with the United States Patent and Trademark Office.

Any unauthorized use, publication or infringement of this designation without express written permission is prohibited.

Such violation is subject to liability for damages, injunctive relief, attorney’s fees and other penalties, civil and criminal.

Ebola Outbreak Map®

https://www.ebolaoutbreakmap.com

TRADEMARK REGISTRATION # 4759271

Ebola Outbreak Map registered trademark is for sale.

Imagine the possibilities of having exclusive rights for an Ebola Map.

IC 035. US 100 101 102. G & S: Advertising and directory services, namely, promoting the services of others by providing a web page featuring links to the websites of others; Marketing the goods and services of others by hyperlinking and placing ads on a website; Promoting and marketing the goods and services of others by offering ad space on a website to place ads; Promoting the goods and services of others by offering ad space on a website to place ads; Provision of space on websites for advertising goods and services.

Ebola Outbreak Map Trademark and Licensing can be purchased.

10% finder’s fee will be paid from the total trademark sale amount to anyone who finds a buyer for the trademark Ebola Outbreak Map.

Interested parties may submit their trademark purchase requests via email: support@ebolaoutbreakmap.com